The Challenges of Performing Exome Sequencing in Structurally Normal Fetuses.
作者信息
Chandler Natalie, Holder-Espinasse Muriel, Mone Fionnuala
机构信息
North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Clinical Genetics Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
出版信息
Prenat Diagn. 2025 Mar;45(3):294-298. doi: 10.1002/pd.6687. Epub 2024 Oct 11.
Abstract
摘要
相似文献
1
The Challenges of Performing Exome Sequencing in Structurally Normal Fetuses.对结构正常胎儿进行外显子组测序的挑战。
Prenat Diagn. 2025 Mar;45(3):294-298. doi: 10.1002/pd.6687. Epub 2024 Oct 11.
2
Exome sequencing for structurally normal fetuses-yields and ethical issues.外显子组测序在结构正常胎儿中的应用——结果与伦理问题。
Eur J Hum Genet. 2023 Feb;31(2):164-168. doi: 10.1038/s41431-022-01169-9. Epub 2022 Sep 7.
3
Next-Generation Sequencing Gene Panels and "Solo" Clinical Exome Sequencing Applied in Structurally Abnormal Fetuses.下一代测序基因面板和“独奏”临床外显子组测序在结构异常胎儿中的应用。
Fetal Diagn Ther. 2021;48(10):746-756. doi: 10.1159/000519701. Epub 2021 Nov 12.
4
Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges.产前外显子组测序在异常胎儿中的应用：新的机遇和挑战。
Genet Med. 2017 Nov;19(11):1207-1216. doi: 10.1038/gim.2017.33. Epub 2017 May 18.
5
Navigating the Challenges of Exome Sequencing in Structurally Normal Fetuses.应对结构正常胎儿外显子组测序的挑战
Prenat Diagn. 2025 Mar;45(3):273-275. doi: 10.1002/pd.6766.
6
Incremental yield of exome sequencing over standard prenatal testing in structurally normal fetuses: systematic review and meta-analysis.结构正常胎儿中外显子组测序相对于标准产前检测的增量收益：系统评价与荟萃分析
Ultrasound Obstet Gynecol. 2025 May;65(5):552-559. doi: 10.1002/uog.29195. Epub 2025 Feb 17.
7
Exome sequencing in every pregnancy? Results of trio exome sequencing in structurally normal fetuses.每次怀孕都进行外显子组测序？结构正常胎儿的三联体外显子组测序结果。
Prenat Diagn. 2025 Mar;45(3):276-286. doi: 10.1002/pd.6585. Epub 2024 May 12.
8
Novel and recurrent variants identified in fetuses with central nervous system abnormalities by trios-medical exome sequencing.通过三联体医学外显子组测序在患有中枢神经系统异常的胎儿中鉴定出的新型和复发性变异。
Clin Chim Acta. 2020 Nov;510:599-604. doi: 10.1016/j.cca.2020.08.018. Epub 2020 Aug 14.
9
Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities.用于超声异常胎儿产前诊断的外显子组测序
Prenat Diagn. 2015 Oct;35(10):1010-7. doi: 10.1002/pd.4675. Epub 2015 Sep 11.
10
Whole-exome sequencing increases the diagnostic rate for prenatal fetal structural anomalies.全外显子组测序提高了产前胎儿结构畸形的诊断率。
Eur J Med Genet. 2021 Sep;64(9):104288. doi: 10.1016/j.ejmg.2021.104288. Epub 2021 Jul 9.
引用本文的文献
1
Incremental yield of exome sequencing over standard prenatal testing in structurally normal fetuses: systematic review and meta-analysis.结构正常胎儿中外显子组测序相对于标准产前检测的增量收益：系统评价与荟萃分析
Ultrasound Obstet Gynecol. 2025 May;65(5):552-559. doi: 10.1002/uog.29195. Epub 2025 Feb 17.
本文引用的文献
1
Exome sequencing in every pregnancy? Results of trio exome sequencing in structurally normal fetuses.每次怀孕都进行外显子组测序？结构正常胎儿的三联体外显子组测序结果。
Prenat Diagn. 2025 Mar;45(3):276-286. doi: 10.1002/pd.6585. Epub 2024 May 12.
2
Monogenic conditions and central nervous system anomalies: A prospective study, systematic review and meta-analysis.单基因疾病与中枢神经系统异常：一项前瞻性研究、系统综述和荟萃分析。
Prenat Diagn. 2024 Apr;44(4):422-431. doi: 10.1002/pd.6466. Epub 2023 Dec 6.
3
Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria.计算工具的校准用于错义变异致病性分类和 ClinGen 对 PP3/BP4 标准的建议。
Am J Hum Genet. 2022 Dec 1;109(12):2163-2177. doi: 10.1016/j.ajhg.2022.10.013. Epub 2022 Nov 21.
4
Exome sequencing for structurally normal fetuses-yields and ethical issues.外显子组测序在结构正常胎儿中的应用——结果与伦理问题。
Eur J Hum Genet. 2023 Feb;31(2):164-168. doi: 10.1038/s41431-022-01169-9. Epub 2022 Sep 7.
5
Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta-analysis.外显子组测序在产前诊断胎儿结构畸形中的诊断效能：系统评价和荟萃分析。
Prenat Diagn. 2022 May;42(6):662-685. doi: 10.1002/pd.6115. Epub 2022 May 7.
6
Population-Based Penetrance of Deleterious Clinical Variants.基于人群的有害临床变异的外显率。
JAMA. 2022 Jan 25;327(4):350-359. doi: 10.1001/jama.2021.23686.
7
A framework for reporting secondary and incidental findings in prenatal sequencing: When and for whom?产前测序中次要和偶然发现的报告框架：何时以及为谁报告？
Prenat Diagn. 2022 May;42(6):697-704. doi: 10.1002/pd.6097. Epub 2022 Jan 19.
8
High rate of abnormal findings in Prenatal Exome Trio in low risk pregnancies and apparently normal fetuses.在低风险妊娠和明显正常胎儿的产前外显子组三检测中，异常发现率较高。
Prenat Diagn. 2022 May;42(6):725-735. doi: 10.1002/pd.6077. Epub 2021 Dec 17.
9
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).临床外显子组和基因组测序中次要发现报告的建议，2021年更新：美国医学遗传学与基因组学学会（ACMG）政策声明
Genet Med. 2021 Aug;23(8):1391-1398. doi: 10.1038/s41436-021-01171-4. Epub 2021 May 20.
10
A Bayesian method to estimate variant-induced disease penetrance.贝叶斯方法估计变异引起的疾病外显率。
PLoS Genet. 2020 Jun 22;16(6):e1008862. doi: 10.1371/journal.pgen.1008862. eCollection 2020 Jun.
Zotero 插件